Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT02393209 · TERMINATED
Trial details
- NCT number
- NCT02393209
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-03
- Primary completion
- 2017-01-12
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.